LEADER 01718nam  2200457Ia 450 
001 9910697577703321
005 20081202114117.0
035   $a(CKB)5470000002389173
035   $a(OCoLC)276856048
035   $a(EXLCZ)995470000002389173
100   $a20081202d2007      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe distribution of fluoxetine and norfluoxetine in postmortem fluids and tissues$b[electronic resource] /$fRussell J. Lewis, Robert D. Johnson, Mike K. Angier
210  1$aWashington, DC :$cFederal Aviation Administration, Office of Aerospace Medicine,$d[2007]
215   $ai, 7 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on Dec. 2, 2008).
300   $a"June 2007."
300   $a"DOT/FAA/AM-07/15."
320   $aIncludes bibliographical references (page 7).
606   $aForensic pharmacology$zUnited States
606   $aFluoxetine$xAnalysis
606   $aAir pilots$xDrug use$zUnited States
606   $aAircraft accidents$xInvestigation$zUnited States
615  0$aForensic pharmacology
615  0$aFluoxetine$xAnalysis.
615  0$aAir pilots$xDrug use
615  0$aAircraft accidents$xInvestigation
700   $aLewis$b Russell J$01382528
701   $aJohnson$b Robert D$g(Robert David),$f1974-$01382527
701   $aAngier$b Mike K$01384636
712 02$aUnited States.$bOffice of Aerospace Medicine.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697577703321
996   $aThe distribution of fluoxetine and norfluoxetine in postmortem fluids and tissues$93504315
997   $aUNINA